AbsEn.i
Exploration
Accueil
Racine
Exploration
Accueil

Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « AbsEn.i » - entrée « term »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
terfenadine < term < termed  Facettes :

List of bibliographic references indexed by term

Number of relevant bibliographic references: 66.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000037 (2021) Isabel Fambuena-Muedra [Espagne] ; Marta Jiménez-García [Belgique] ; Sarah Hershko [Belgique] ; Irene Altemir-G Mez [Espagne] ; Ana Tobarra-L Pez [Espagne]What can visual caregivers expect with patients treated for SARS-CoV-2? An analysis of ongoing clinical trials and ocular side effects.
000068 (2021) Cassandra Doyno [États-Unis] ; Diana M. Sobieraj [États-Unis] ; William L. Baker [États-Unis]Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose.
000078 (2021) Ales Janda [Allemagne] ; Catharina Schuetz [Allemagne] ; Scott Canna [États-Unis] ; Mark Gorelik [États-Unis] ; Maximilian Heeg [Allemagne] ; Kirsten Minden [Allemagne] ; Claas Hinze [Allemagne] ; Ansgar Schulz [Allemagne] ; Klaus-Michael Debatin [Allemagne] ; Christian M. Hedrich [Royaume-Uni] ; Fabian Speth [Allemagne]Therapeutic approaches to pediatric COVID-19: an online survey of pediatric rheumatologists.
000097 (2021) Jack Cook [États-Unis] ; Milton L. Pressler [États-Unis] ; Bharat Damle [États-Unis] ; Demissie Alemayehu [États-Unis] ; Charles A. Knirsch [États-Unis]The Weight of Evidence From Electrophysiology, Observational, and Cardiovascular End Point Studies Demonstrates the Safety of Azithromycin.
000109 (2021) Hailey Olds [États-Unis] ; Jesse Liu [États-Unis] ; Kevin Luk [États-Unis] ; Henry W. Lim [États-Unis] ; David Ozog [États-Unis] ; Pranita V. Rambhatla [États-Unis]Telogen effluvium associated with COVID-19 infection.
000141 (2021) Zhi-Yuan Pan [République populaire de Chine] ; Yu-Xiao Chang [République populaire de Chine] ; Ni Han [République populaire de Chine] ; Feng-Yi Hou [République populaire de Chine] ; B J Yang Lee [République populaire de Chine] ; Fa-Chao Zhi [République populaire de Chine] ; Rui-Fu Yang [République populaire de Chine] ; Yu-Jing Bi [République populaire de Chine]Short-term high-dose gavage of hydroxychloroquine changes gut microbiota but not the intestinal integrity and immunological responses in mice.
000275 (2021) Antonio Ceriello [Italie] ; Francesco Prattichizzo [Italie]Pharmacological management of COVID-19 in type 2 diabetes.
000580 (2021) Hercílio Martelli Júnior [Brésil] ; Nelson Pereira Marques [Oman] ; Nádia Carolina Teixeira Marques [Brésil] ; Edson Gomes De Lucena [Brésil] ; Daniella Reis B. Martelli [Brésil] ; Eduardo A. Oliveira [Brésil]Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine'.
000581 (2021) Sarthak Gupta ; Shuichiro Nakabo [États-Unis] ; Jun Chu [États-Unis] ; Sarfaraz Hasni [États-Unis] ; Mariana J. Kaplan [États-Unis]Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine'.
000678 (2021) Bin Zhou [Japon] ; Shinsuke Kojima [Japon] ; Atsuhiko Kawamoto [Japon] ; Masanori Fukushima [Japon]COVID-19 pathogenesis, prognostic factors, and treatment strategy: Urgent recommendations.
000744 (2021) Omkar Indari [Inde] ; Shweta Jakhmola [Inde] ; Elangovan Manivannan [Inde] ; Hem Chandra Jha [Inde]An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come?
000932 (2020) S. Defoort-Dhellemmes [France][Is there a need for ophthalmological surveillance in the case of short-term hydroxychloroquine treatment during this COVID-19 pandemic?]
000934 (2020) Ezequiel J. Zaidel [Oman] ; Fernando S. Wyss Quintana ; Álvaro Sosa Liprandi ; Iván Mendoza ; Manlio F. Márquez ; Elaine Nu Ez ; Marcia Barbosa ; Adrián Baranchuk[Hydroxychloroquine. Cardiology's viewpoint in times of coronavirus pandemic].
000961 (2020) Mohammad Obeidat [États-Unis] ; Alexandra L. Isaacson [États-Unis] ; Stephanie J. Chen [États-Unis] ; Marina Ivanovic [États-Unis] ; Danniele Holanda [États-Unis]Zebra-like bodies in COVID-19: is phospholipidosis evidence of hydroxychloroquine induced acute kidney injury?
000969 (2020) Issam Nessaibia [Algérie, Italie] ; Dafne Siciliano [Italie] ; Abdelkrim Tahraoui [Algérie]Why nobody discusses the adverse psychiatric effects of chloroquine in case it might become the future treatment against COVID-19?
000A28 (2020) A B Bayoumy [Pays-Bas] ; N K H. De Boer [Pays-Bas] ; A R Ansari [Royaume-Uni] ; F. Crouwel [Pays-Bas] ; C J J. Mulder [Pays-Bas]Unrealized potential of drug repositioning in europe during COVID-19 and beyond: a physcian's perspective.
000A80 (2020) Marilù Bartiromo [Italie] ; Beatrice Borchi [Italie] ; Annarita Botta [Italie] ; Alfredo Bagalà [Italie] ; Gianmarco Lugli [Italie] ; Marta Tilli [Italie] ; Annalisa Cavallo [Italie] ; Brunilda Xhaferi [Italie] ; Roberta Cutruzzulà [Italie] ; Augusto Vaglio [Italie] ; Silvia Bresci [Italie] ; Aida Larti [Italie] ; Alessandro Bartoloni [Italie] ; Calogero Cirami [Italie]Threatening drug-drug interaction in a kidney transplant patient with coronavirus disease 2019 (COVID-19).
000B49 (2020) Jung-Hyun Won [Corée du Sud] ; Howard Lee [Corée du Sud]The Current Status of Drug Repositioning and Vaccine Developments for the COVID-19 Pandemic.
000B72 (2020) Stephan Grabbe [Allemagne] ; Stefan Beissert [Allemagne] ; Alexander Enk [Allemagne]Systemic immunosuppression in times of COVID-19: Do we need to rethink our standards?
000B86 (2020) Yu Kang ; Hui Wang ; Hong Chen ; Bo Wang ; Yingying Yang ; Xuan Zhao ; Qihui Ran ; Jiafu WeiSuspected Hydroxychloroquine-Induced Sinus Bradycardia and QTc Prolongation in a Patient with COVID-19.
000B93 (2020) Feng He [République populaire de Chine] ; Qingqing Luo [République populaire de Chine] ; Ming Lei [République populaire de Chine] ; Lixin Fan [République populaire de Chine] ; Xinning Shao [République populaire de Chine] ; Kaiyuan Hu [République populaire de Chine] ; Shuguang Qin [République populaire de Chine] ; Na Yu [République populaire de Chine] ; Jie Cao [République populaire de Chine] ; Liuping Yang [République populaire de Chine]Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "term" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "term" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    term
}}
Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021